Claudio Mori

Claudio Mori

Vifor Pharma - / Switzerland
Others
AD Scientific Index ID: 4970722
person_outline Claudio Mori's MOST POPULAR ARTICLES
1-) Ferric carboxymaltose in patients with heart failure and iron deficiency SD Anker, J Comin Colet, G Filippatos, R Willenheimer, K Dickstein, ... New England Journal of Medicine 361 (25), 2436-2448, 2009 21172009
2-) Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency P Ponikowski, DJ Van Veldhuisen, J Comin-Colet, G Ertl, M Komajda, ... European heart journal 36 (11), 657-668, 2015 10732015
3-) Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron‐deficient heart failure patients: an individual patient data meta‐analysis SD Anker, BA Kirwan, DJ van Veldhuisen, G Filippatos, J Comin‐Colet, ... European journal of heart failure 20 (1), 125-133, 2018 3712018
4-) Intravenous ferric carboxymaltose in iron‐deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR‐HF trialG Filippatos, D Farmakis, JC Colet, K Dickstein, TF Lüscher, ...European journal of heart failure 15 (11), 1267-1276, 20132072013
5-) The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF studyJ Comin-Colet, M Lainscak, K Dickstein, GS Filippatos, P Johnson, ...European heart journal 34 (1), 30-38, 20131962013